{"abortion spontaneous": 2.5, "adverse drug reaction": 2.33, "adverse event": 2.51, "anal abscess": 19.04, "bronchitis": 2.91, "cellulitis": 6.04, "clostridium difficile infection": 4.74, "colitis ulcerative": 21.79, "crohn's disease": 24.97, "cytomegalovirus infection": 4.4, "disseminated tuberculosis": 53.77, "drug hypersensitivity": 4.23, "drug level decreased": 8.12, "exposure during pregcy": 6.48, "fistula": 16.49, "foetal exposure during pregcy": 2.18, "frequent bowel movements": 12.09, "fungal infection": 5.14, "haematochezia": 2.62, "infusion related reaction": 35.71, "interstitial lung disease": 5.72, "intestinal obstruction": 3.74, "liver disorder": 2.29, "lower respiratory tract infection": 2.24, "lupus-like syndrome": 34.82, "lymphoma": 5.49, "off label use": 2.39, "osteoarthritis": 2.27, "pneumocystis jirovecii pneumonia": 15.74, "pneumonia": 3.27, "premature baby": 6.39, "product use issue": 4.06, "psoriasis": 4.75, "pulmonary tuberculosis": 17.51, "rectal haemorrhage": 2.52, "rheumatoid arthritis": 3.46, "sinusitis": 3.2, "staphylococcal infection": 4.92, "therapeutic product effect decreased": 4.18, "therapeutic product effect incomplete": 2.51, "therapeutic response decreased": 5.66, "tuberculosis": 10.74, "urinary tract infection": 2.29, "vasculitis": 2.81, "weight decreased": 2.35, "white blood cell count increased": 2.27}